Our Methodology

TwinCalc applies a multiplicative risk-factor model to a 1.5% population baseline, capped at 25%. Each factor below is presented with the evidence we relied on, the effect size we use, the weight in the formula, and the primary sources.

Last updated:

Abstract

TwinCalc estimates the probability of conceiving twins using a multiplicative risk-factor model applied to a 1.5% global baseline. We chose a multiplicative form because the underlying mechanisms — hyperovulation, implantation rate, embryo transfer policies — combine roughly independently in published epidemiological data. The result is capped at 25% to keep extreme compounding from producing unrealistic outputs.

Baseline

The 1.5% baseline corresponds to the global twin pregnancy rate prior to the recent rise driven by ART and later maternal age. National rates are higher (the United States is around 3.2% per live birth) but include the very factors we measure separately, which is why we anchor the model on a pre-ART baseline.

Maternal age

Evidence. NCHS reports that twin birth rates climb steeply with age, peaking between 35 and 39, then declining. The mechanism is well documented: rising FSH levels with age can trigger multifollicular ovulation.

Effect size. ×0.8 (under 25) to ×4.0 (35–39), ×3.0 (40+)

Weighting. Categorical band, multiplicative on baseline.

Source: NCHS Vital Statistics Source: Beemsterboer et al., 2006

IVF and assisted reproduction

Evidence. ASRM and HFEA registries consistently show that double-embryo transfer roughly triples to quadruples twin rates compared to natural conception. Single-embryo transfer policies have reduced this in some regions.

Effect size. ×3.5 with ART, ×1.0 without

Weighting. Binary multiplier; future versions will model SET vs DET separately.

Source: ASRM, 2024 Source: CDC ART Surveillance

Family history

Evidence. Hyperovulation has heritable components transmitted through the maternal line; paternal ancestry contributes a smaller, indirect effect via daughters.

Effect size. ×2.5 maternal, ×1.2 paternal

Weighting. Independently multiplicative; both can apply.

Source: ACOG family history guidance Source: Painter et al., 2010

Ethnicity

Evidence. Population studies have documented twin rates from roughly 5/1,000 in East Asia to over 30/1,000 in parts of West Africa. The hyperovulation gradient is partly genetic.

Effect size. ×0.5 (East Asian) to ×3.0 (West African)

Weighting. Categorical multiplier.

Source: WHO collaborative study Source: Smits & Monden, 2011

Height & BMI

Evidence. Taller women and women with BMI ≥ 30 show modest increases in dizygotic twinning, plausibly mediated by IGF-1.

Effect size. ×0.9 to ×1.5 (height); ×0.95 to ×1.3 (BMI)

Weighting. Two independent multipliers.

Source: Reproductive Sciences, 2006 Source: Obstetrics & Gynecology, 2005

Contraception history

Evidence. A short FSH rebound after stopping the pill has been associated with a slight rise in twin probability in the first cycles.

Effect size. ×1.2 if stopped within 3 months

Weighting. Time-limited, decays to baseline.

Source: Human Reproduction, 2014

Previous pregnancies

Evidence. Multiparity is associated with a small but consistent uplift in dizygotic twinning, likely linked to gradual hormonal shifts.

Effect size. ×1.0 (P0) to ×1.3 (P3+)

Weighting. Categorical band.

Source: ACOG parity guidance

Currently breastfeeding

Evidence. Limited but reproducible data suggest that ovulation resuming during lactation is associated with elevated twin probability.

Effect size. ×1.4

Weighting. Binary multiplier; under review for future versions.

Source: Steinman G., 2006

Limitations & disclaimers

  • •This calculator provides population-based estimates and is not a clinical prediction tool.
  • •The multiplicative model assumes near-independence between factors. Some factors (age and ART, for example) interact in ways we approximate.
  • •Effect sizes for ethnicity reflect aggregate population data and do not predict individual genetic predisposition.
  • •Results are capped at 25% to communicate uncertainty at high compound multipliers.
  • •This tool does not replace medical advice. Consult a qualified clinician for personal guidance.

Full bibliography

  1. [1] National Center for Health Statistics. (2023). Births: Final data for 2022. National Vital Statistics Reports.
  2. [2] American Society for Reproductive Medicine. (2024). Guidelines on the number of embryos transferred.
  3. [3] American College of Obstetricians and Gynecologists. (2022). Clinical management of multiple gestation.
  4. [4] Smits J, Monden C. (2011). Twinning across the developing world. PLoS ONE.
  5. [5] Beemsterboer SN, et al. (2006). The paradox of declining fertility but increasing twinning rates with advancing maternal age. Human Reproduction.
  6. [6] Steinman G. (2006). Mechanisms of twinning: VII. Effect of diet and heredity on the human twinning rate. Journal of Reproductive Medicine.
  7. [7] Painter JN, et al. (2010). A genome-wide linkage scan for dizygotic twinning. Twin Research & Human Genetics.

A monthly briefing on twin science

One careful email a month — new factor pages, study updates, no spam.